Is there an interplay between adherence to mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients? by PASTORI, DANIELE et al.
1 
1 
 
A
n
ti
o
x
id
an
ts
 a
n
d
 R
ed
o
x
 S
ig
n
al
in
g
 
Is
 t
h
er
e 
an
 i
n
te
rp
la
y
 b
et
w
ee
n
 a
d
h
er
en
ce
 t
o
 M
ed
it
er
ra
n
ea
n
 d
ie
t,
 a
n
ti
o
x
id
an
t 
st
at
u
s 
an
d
 v
as
cu
la
r 
d
is
ea
se
 i
n
 a
tr
ia
l 
fi
b
ri
ll
at
io
n
 p
at
ie
n
ts
? 
(d
o
i:
 1
0
.1
0
8
9
/a
rs
.2
0
1
6
.6
8
3
9
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Is there an interplay between adherence to Mediterranean diet, antioxidant status and vascular 
disease in atrial fibrillation patients? 
 
Daniele Pastori MD(1)*, Roberto Carnevale PhD(1,2)*, Danilo Menichelli(1), Cristina Nocella PhD(1), 
Simona Bartimoccia PhD(1), Marta Novo BSc(1),  Isabella Leo MD(1), Francesco Violi MD(1)**, 
Pasquale Pignatelli MD(1) 
(1) I Clinica Medica, Atherothrombosis Centre, Department of Internal Medicine and Medical 
Specialties, Sapienza University of Rome 
(2) Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 
Latina, Italy. 
* equal contribution 
** joint senior authorship 
 
Running title: Mediterranean Diet and glutathione peroxidase 3 
 
 
Correspondence to Professor Pasquale Pignatelli, I Clinica Medica, Viale del Policlinico 155, Roma, 
00161, Italy. Phone: +390649977777; fax +390649970103; e-mail: 
pasquale.pignatelli@uniroma1.it 
Conflict of interest: none. 
 
Keywords: mediterranean diet, glutathione peroxidase 3, cardiovascular events, antioxidants 
 
Word count: 2703 
  
Antioxidants and Redox Signaling 
                        © Mary Ann Liebert, Inc.  
                        DOI: 10.1089/ars.2016.6839 
 Page 1 of 16 
A
nt
io
xi
da
nt
s &
 R
ed
ox
 S
ig
na
lin
g
Is
 th
er
e 
an
 in
te
rp
la
y 
be
tw
ee
n 
ad
he
re
nc
e 
to
 M
ed
ite
rra
ne
an
 d
ie
t, 
an
tio
xi
da
nt
 st
at
us
 a
nd
 v
as
cu
la
r d
ise
as
e 
in
 a
tri
al
 fi
br
ill
at
io
n 
pa
tie
nt
s?
 (d
oi:
 10
.10
89
/ar
s.2
01
6.6
83
9)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
2 
2 
 
A
n
ti
o
x
id
an
ts
 a
n
d
 R
ed
o
x
 S
ig
n
al
in
g
 
Is
 t
h
er
e 
an
 i
n
te
rp
la
y
 b
et
w
ee
n
 a
d
h
er
en
ce
 t
o
 M
ed
it
er
ra
n
ea
n
 d
ie
t,
 a
n
ti
o
x
id
an
t 
st
at
u
s 
an
d
 v
as
cu
la
r 
d
is
ea
se
 i
n
 a
tr
ia
l 
fi
b
ri
ll
at
io
n
 p
at
ie
n
ts
? 
(d
o
i:
 1
0
.1
0
8
9
/a
rs
.2
0
1
6
.6
8
3
9
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Abstract 
Mediterranean Diet (Med-Diet) is associated with reduced incidence of vascular events (VEs) in 
atrial fibrillation (AF), but the mechanism accounting for its beneficial effect is only partially 
known. We hypothesized that Med-Diet may reduce VEs by improving antioxidant status, as 
assessed by glutathione peroxidase 3 (GPx3) and superoxide dismutase (SOD). We performed a 
prospective cohort study investigating the relationship between adherence to Med-Diet, serum 
baseline GPx3 and SOD activities, and the occurrence of vascular events (VEs) in 690 AF patients. 
GPx3 activity was directly associated with Med-Diet score (B=0.192, p<0.001) and inversely with 
age (B=-0.124, p=0.001), after adjustment for potential confounders; Med-Diet weakly affected 
SOD levels. During a mean follow-up of 46.1±28.2 months, 89 VEs were recorded; patients with 
VEs had lower GPx3 levels compared to those without (p=0.002); no differences regarding SOD 
activity were found. Multivariable Cox regression analysis showed that age (Hazard ratio 
[HR]:1.065, p<0.001), logGPx3 (above median, HR:0.629, p<0.05) and Med-Diet score (HR:0.547, 
p<0.05) predicted VEs. Med-Diet favourably modulates antioxidant activity of GPx3 in AF resulting 
in reduced VEs rate. We hypothesize that modulating GPx3 levels by Med-Diet could represent an 
additional nutritional strategy to prevent VEs in AF patients.  
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Introduction 
Atrial Fibrillation (AF) patients disclose several atherosclerotic risk factors that may complicate 
their clinical course, by increasing the rate of thrombotic complications, such as ischemic stroke 
and myocardial infarction. Oxidative stress plays a key role in this setting, as it is implicated not 
only in promoting and maintaining AF but also in increasing the risk for cardiovascular events in AF 
patients. Another piece of information in this field has been provided by a recent study, in which 
we demonstrated that the activity of NADPH oxidase, an enzymatic system generating reactive 
oxygen species (ROS), is predictive of cardiovascular events in this setting(5). 
The role of Mediterranean Diet (Med-Diet) in reducing the incidence of cardiovascular events is 
well established; thus, large prospective cohort studies investigated the relationship between the 
adherence to Med-Diet and incidence of cardiovascular events, and demonstrated that Med-Diet 
was effective both in primary and secondary prevention.  
So far, the cardio protective property of Med-Diet has been mainly attributed to its ability to 
prevent, or improve, cardio-metabolic disease such as diabetes, obesity and dyslipidaemia. More 
recently, Med-Diet has been shown to be able to modulate oxidative stress, via reduction of Nox2-
derived oxidative stress. The human body possesses natural antioxidants that maintain the redox 
status by counteracting the excess of ROS. Among them, the glutathione peroxidase (GPx) family 
plays an important role by catabolizing hydrogen peroxide, which is an oxidant species with pro-
aggregating property. In addition to GPx, the thioredoxin system is emerging as another major 
buffer of H2O2, by preventing unremitted H2O2 emission from mitochondria in the heart tissue(9). 
Recent study from our group demonstrated an inverse relationship between GPx3, the soluble 
isoform of GPx family, and cardiovascular events in a population with AF(6). We speculated that 
Med-Diet might positively influence vascular outcomes via up-regulation of GPx3. Aim of the study 
was to investigate the relationship between adherence to Med-Diet and circulating GPx3 in a 
population with AF. 
Results 
Among the entire cohort, 30 patients were excluded and 690 entered the study. Table 1 reports 
characteristics of patients. Overall, median Med-Diet score was 5.0 [4.0-6.0] points. In particular, 
olive oil consumption was present in 92.0%, fruit in 88.1%, vegetable/salad 68.4%, combined fruit 
and vegetable in 63.3%, legumes in 37.7%, fish in 14.5%, wine in 36.5%, low meat in 74.5% and 
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low bread/rice 34.9%. Median GPx3 activity was 21.0 [12.0-34.0] U/ml (logGPx3 2.99±0.7), median 
SOD was 2.1 [1.3-3.2] U/ml (logSOD 0.77±0.5).  
GPx3, SOD and Med-Diet. Med-Diet score was significantly correlated with logGPx3 (r=0.191 
p<0.001). A significant difference across tertiles of Med-Diet score was observed for mean values 
of logGPx3 levels (Fig.1, p <0.001; 1st vs. 3rd tertile of Med-Diet score, p<0.001, 2nd vs. 3rd tertile of 
Med-Diet score, p=0.017). In a multivariable stepwise linear regression analysis, Med-Diet score 
(B=0.192, p<0.001) and inversely with age (B=-0.124, p=0.001) were directly associated with 
logGPx3, after adjustment for potential confounders (see Methods). Using single foods as 
covariates (with the exception of the item 4 of combined use of fruit and vegetable), we found 
that vegetable/salad (B=0.130, p<0.001), fruit (B: 0.080, p=0.037) and wine (B=0.076, p=0.041) 
were directly associated with logGPx3 levels, while age remained inversely associated (B=-0.128, 
p=0.001). 
SOD levels were correlated with Med-Diet adherence score (r=0.077, p=0.044). At the 
multivariable stepwise linear regression analysis a direct association between levels of logSOD and 
Med-Diet score (B=0.077, p=0.042) was found, while arterial hypertension (B=-0.075, p=0.048) was 
inversely associated. The same analysis using logSOD as dependent variable, showed that fish 
(B=0.081, p=0.033), and arterial hypertension (B=-0.075, p=0.049) were independently associated 
with SOD levels. 
 
Antioxidant enzymes, VEs and Med-Diet. During a mean follow-up of 46.1±28.2 months, 89 
patients experienced VEs: 22 ischemic strokes, 18 cardiac revascularizations, 25 MIs, 3 VTE, 17 
cardiovascular deaths and 4 systemic embolisms. 
Compared to those without, patients with VEs had significantly lower GPx3 levels [14.0 (10.0-25.0) 
vs. 21.0 (12.0-36.0), p=0.002]. Patients with MI/cardiac revascularization and cerebrovascular 
events had similar GPx3 values [12.0 (9.0-25.0) vs. 12.0 (7.5-21.0), p=0.500]; patients with 
cardiovascular death tended to have slightly higher GPx3 levels [18.0 (10.0-25.0), vs. cerebral and 
cardiac events 12.0 (18.0-24.0), p=0.312].  
No differences regarding SOD activity were found (p=0.747); thus, no further survival analysis was 
performed with this enzyme. 
A Kaplan-Meier analysis showed a significant predictive value of low logGPx3 activity (below 
median) for the onset of VEs at follow-up (Figure 1. Log-rank test p=0.012). 
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Med-Diet score was significantly lower in patients with VEs compared to those without (p=0.024). 
At univariate Cox regression analysis we observed a significant risk reduction of VEs for each point 
of Med-Diet adherence score (HR: 0.858, 95%CI 0.748-0.985, p=0.029), and for median value of 
logGPx3 activity (HR: 0.581 95%CI 0.377-0.895, p=0.014). 
In a multivariable Cox regression analysis, age, logGPx3 and Med-Diet score independently 
predicted VEs (Table 2). 
 
Discussion 
The study demonstrated that GPx3 levels are favourably influenced by adherence to Med-Diet. 
Previous investigations on the relationship between Med-Diet and GPx3 levels reported 
controversial results. Thus, an analysis conducted in 372 subjects enrolled in the PREDIMED study 
evidenced a lack of correlation between the interventional study with a traditional Med-Diet and 
serum GPx activity (3). However, laboratory analysis was restricted to total GPx activity without 
discriminating among GPx isoforms. 
On the other hand, a positive correlation between adherence to the Med-Diet and reduced levels 
of GPx activity was found in an observational study on 149 twins by Day and colleagues (2). The 
Authors performed an intriguing study including twins so excluding early environmental or genetic 
confounding factors potentially affecting GPx activity. Nevertheless, this study is difficult to be 
translated into the general population, as it was performed only in male young subjects and 
investigated only total GPx activity. 
In our study, the association between Med-Diet adherence and GPx3 was evidenced on a real 
high-risk population, as it is the one represented by AF patients. Thus, patients presented a cluster 
of different risk factors with a high prevalence of hypertension, previous cardiovascular or 
cerebrovascular events. Moreover, we included patients of both genders. 
It is also clinically relevant that our study analysed a specific GPx isoform, namely GPx3, that 
seems to be associated to the occurrence of platelet-dependent thrombotic events as evidenced 
in animal and human models of Gpx3 deficiency(4). Previous study from our groups demonstrated, 
in fact, a key role for H202 in eliciting platelet activation via thromboxane A2 over-production(7). 
As GPx3  degrades H202, its reduced activity predisposes to platelet activation and eventually 
thrombosis. In accordance with this hypothesis, we have previously demonstrated an inverse 
association between GPx3 activity and thromboxane biosynthesis(6). 
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In this context, Med-Diet, which does not interfere with anticoagulation stability, may be a 
suitable tool to enhance GpX3 activity in AF patients. The exact mechanism for this association is 
difficult to be deduced from an observational study; it is possible that some specific components 
of Med-Diet, such as resveratrol, may play a role via up-regulation of the mRNA expression of SOD 
and GPx but other components cannot be excluded(8). Thus, Med-Diet contains nutrients rich of    
antioxidants such as vitamin C and E, carotenoids, and flavonoids, which may contribute to the 
increase of GPx3 activity. 
To further explore the relationship between Med-diet and antioxidants, we also investigated the 
relationship between adherence to Med-Diet and SOD activity, which has been shown to be 
associated to an increased rate of cardiovascular events in AF(6). However, though significant, the 
relationship between adherence to Med-Died and plasma SOD was weak.  
Previous study evaluated the relationship between GPx isoforms and cardiovascular events. Thus, 
a prospective study involving 636 patients with suspected coronary heart disease showed an 
inverse relationship between the activity of the enzyme and the risk of cardiovascular events in a 
follow-up period of 4.7 years(1). We also investigated the interplay between GPx3 and VEs. Thus, 
after dividing the cohort into median value of GPx3 levels, we found that patients below the 
median activity of GPx3 were at higher risk of VEs in a long-term follow-up. Altogether, these data 
suggest that GPx isoforms may play a key role in the onset and progression of cardiovascular 
disease. Interestingly, we observed a significant risk reduction of VEs for each point of Med-Diet 
score adherence and for median value of logGPx3 activity suggesting a role for Med-Diet in 
protecting from VEs by influencing GPx3 levels. 
The study has implications and limitations. A clinical implication of the study is that, no effective 
therapeutic options have been described so far to modulate antioxidant activity of GPx3 either in 
primary or in secondary prevention. For instance, clinical trials with selenium supplements, a 
cofactor of GPx, failed to induce any increase in GPx. The increased level of GPx3 associated to the 
high adherence to this dietary regimen suggests that nutrients from Med-Diet may favourably 
affect GPx3 activity; an interventional study with specific component of Med-Diet is necessary to 
support this finding.  Moreover this study is performed on high-risk patients mostly on primary 
prevention thereby the results cannot be extrapolated to patients with established coronary heart 
disease.  
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In conclusion, the results from the present study support the evidence of a positive effect of Med-
Diet in increasing GPx3 resulting in reduced VEs rate. Modulating GPx3 levels by Med-Diet could 
represent an additional nutritional strategy to prevent VEs in AF patients. 
Innovation 
Adherence to Med-Diet diet is associated to a lowered oxidative stress, but it is unknown if it may 
influence the activity of some antioxidant systems, such as GPx3 and SOD. Here we found that 
adherence to Med-Diet is associated to higher GPx3 activity, and that low GPx3 levels predict CVEs 
in high-risk patients such as those affected by atrial fibrillation. The results from this study support 
the hypothesis that Med-Diet could represent an additional nutritional strategy to prevent CVEs in 
AF patients via GPx3 activity up-regulation. 
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NOTES 
Methods 
We performed a prospective, single-center, observational cohort study, including 720 consecutive 
non-valvular AF patients from I Medical Clinic - Atherothrombosis Center of Sapienza University of 
Rome from February 2008 to December 2013. All patients with non-valvular AF, aged >18 years of 
both sexes were included in the study. All patients were treated with vitamin k antagonists, after 
appropriate risk stratification. We excluded patients with mechanical or biologic prosthetic valves, 
severe valvulopathies or history of valvulopasty, congenital heart diseases, severe cognitive 
impairment (e.g Alzheimer’s disease, Parkinson’s disease) and chronic inflammatory diseases. We 
also excluded subjects with evidence of neoplastic diseases, liver cirrhosis, or if they were taking 
any vitamin or antioxidant supplementation. At baseline, for each patient anthropometric data 
were collected as well as data regarding concomitant diseases and treatments. Arterial 
hypertension, diabetes mellitus, and heart failure were classified according to international 
definitions(6). Written informed consent was obtained from all patients. The study was approved 
by the local Ethical Committee and was conducted in accordance with the principles embodied in 
the Declaration of Helsinki. 
Analysis of adherence to Mediterranean Diet 
Adherence to the Med-Diet was assessed by a short dietary questionnaire, which investigated the 
consumption of 9 cardio-protective foods including olive oil, fruit, vegetables or salad, legumes, 
fish, wine, meat and bread/rice, as previously reported(5). 
Blood sampling 
Blood samples were obtained during the enrolment visit. Samples were taken without stasis from 
patients who had fasted for at least 12 h from 7.00 to 8.00 am in serum specific tubes. The tubes 
were incubated for 1 h at 37°C, centrifuged to separate serum, and then frozen at -80°C until 
assayed. 
Analysis of GPx3 and SOD activity 
GPx3 activity was measured in serum by Assay Kit (Abcam). In this assay, glutathione 
peroxidase reduces the probe Cumene Hydroperoxide while converting reduced glutathione to its 
oxidized form, glutathione disulfide. The generated oxidized glutathione is converted into reduced 
glutathione by glutathione reductase, using nicotinamide adenine dinucleotide phosphate as 
reducing agent. GPx3 activity is proportional to the decrease in absorbance of nicotinamide 
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adenine dinucleotide phosphate at 340 nm. One unit of Glutathione peroxidase is defined as the 
amount of enzyme that will cause the oxidation of 1 nmole of nicotinamide adenine dinucleotide 
phosphate (from NADPH to NADP+) per minute at 25°C. Glutathione peroxidase activity was 
expressed as U/ml. Intra- and inter- assays were 4.0% and 6.0%, respectively. Coefficient of 
variation was <10%. 
We measured SOD activity by a colorimetric activity kit (Arbor Assay) in serum samples; 
thus, the extracellular SOD (SOD3) was measured. Samples were incubated with the substrate 
followed by xanthine oxidase reagent. The xanthine oxidase generates superoxide in the presence 
of oxygen, which converts a colourless substrate into a coloured product. The coloured product 
was read at 450 nm. SOD activity was expressed as U/ml. Intra- and inter-assays were 4.6% and 
6.1%, respectively. 
Definition of vascular events (VEs) 
The primary outcome of the study was a composite endpoint of VEs. They included fatal and 
nonfatal ischemic stroke, fatal and nonfatal MI, cardiac or peripheral artery 
revascularization/coronary artery bypass surgery, cardiovascular death and venous 
thromboembolism (VTE). Diagnosis of myocardial Infarction (MI) was made according to the 
international definition as previously reported(6). The occurrence of ischemic stroke was 
diagnosed by motor deficits and confirmed by radiological findings. If a patient died within 4 
weeks of stroke or MI, this event was recorded as fatal stroke or fatal MI. Systemic embolism was 
defined as an acute occlusion of a vessel of an extremity or organ, documented by imaging, 
surgery, or autopsy findings. Cardiovascular death included sudden death; progressive congestive 
heart failure; procedure related death (surgical or percutaneous revascularization); and presumed 
cardiovascular deaths (i.e. those for which a non-cardiovascular cause had not been clearly 
established). The diagnosis of VTE was confirmed by radiology or ultrasonography reports. Only 
the first event that occurred during follow-up was used in the analysis. 
Statistical analysis 
Normal distribution of parameters was assessed by Kolmogorov–Smirnov test. Categorical 
variables were reported as counts (percentage) and continuous variables as means +/- standard 
deviation (SD) or median and interquartile range. Independence of categorical variables was 
tested by χ2 test. Student unpaired t test and Pearson product-moment correlation analysis were 
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used for normally distributed continuous variables. Appropriate nonparametric tests (Mann-
Whitney U test and Spearman rank correlation test) were employed for all the other variables. 
Group comparisons were performed using Fisher’s F-test (ANOVA) or Kruskall-Wallis test when 
needed.  
For the stepwise multivariable linear regression analysis analyses, we used different regression 
model for logGPx3 and SOD values, adjusting for gender, body mass index, history of MI/cardiac 
revascularization, Med-Diet score, smoking, arterial hypertension, diabetes, antiplatelet. To 
investigate the association of single foods with antioxidant enzymes activity, we repeated the 
regression analyses entering single items of dietary questionnaire instead of Med-Diet adherence 
score as covariate. 
After dividing the AF population according to the median value of logGPx3, the cumulative 
incidence was estimated using a Kaplan–Meier product-limit estimator. Survival curves were 
formally compared using the log-rank test. Cox proportional hazards analysis was used to calculate 
the adjusted relative hazards of VEs by each clinical variable. The multivariable analyses were 
performed including the same variables specified above for linear regression analysis. 
Only p values lower than 0.05 were considered as statistically significant. All tests were two-tailed 
and analyses were performed using computer software packages (SPSS-18.0, SPSS Inc.). 
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Figure 1. Values of mean logGPx3 according to the tertiles of the Mediterranean diet adherence 
score. 
Figure 2. Kaplan-Meier survival curves according to the median value of logGPx3. 
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Table 1. Characteristics of study population 
 Overall (n=690) 
Age (years) 72.7±8.0 
Women (%) 41.6 
Body Mass Index (kg/m2) 27.6±4.8 
Mediterranean Diet score# 5.0 [4.0-6.0] 
CHA2DS2-VASc Score
# 3.0 [2.0-4.0] 
Arterial Hypertension (%) 94.6 
Diabetes (%) 19.0 
Previous cerebrovascular events (%) 12.8 
Heart Failure (%) 13.6 
Previous cardiovascular events (%) 20.4 
Antiplatelet drugs (%) 15.2 
#data expressed as median and interquartile range 
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Table 2. Multivariable Cox regression analysis of factors predicting vascular events. 
 Hazard Ratio 95% Confidence Intervals p value 
Med-Diet adherence score 0.547 0.322-0.926 <0.05 
logGPx3 (above median) 0.629 0.406-0.974 <0.05 
Female sex 0.814 0.522-1.270 0.365 
Age 1.065 1.033-1.098 <0.001 
Body mass index 1.025 0.979-1.074 0.293 
Arterial hypertension 0.575 0.227-1.456 0.243 
Diabetes 1.517 0.930-2.475 0.095 
Heart failure 1.404 0.824-2.394 0.212 
Previous cerebrovascular events 1.440 0.841-2.467 0.184 
Previous cardiovascular events 1.352 0.819-2.233 0.238 
Antiplatelet drugs 1.356 0.792-2.320 0.267 
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